4//SEC Filing
Foley Todd 4
Accession 0001104659-15-071610
CIK 0001534120other
Filed
Oct 19, 8:00 PM ET
Accepted
Oct 20, 2:59 PM ET
Size
19.9 KB
Accession
0001104659-15-071610
Insider Transaction Report
Form 4
Cerecor Inc.CERC
Transactions
- Conversion
Common Stock
2015-10-20+595,436→ 595,436 total(indirect: See Footnote) - Conversion
Series B Convertible Preferred Stock
2015-10-20−16,672,224→ 0 total(indirect: See Footnote)→ Common Stock (595,436 underlying)
MPM BIOVENTURES V GP LLC
10% Owner
Transactions
- Conversion
Series B Convertible Preferred Stock
2015-10-20−16,672,224→ 0 total(indirect: See Footnote)→ Common Stock (595,436 underlying) - Conversion
Common Stock
2015-10-20+595,436→ 595,436 total(indirect: See Footnote)
MPM BIOVENTURES V LLC
10% Owner
Transactions
- Conversion
Common Stock
2015-10-20+595,436→ 595,436 total(indirect: See Footnote) - Conversion
Series B Convertible Preferred Stock
2015-10-20−16,672,224→ 0 total(indirect: See Footnote)→ Common Stock (595,436 underlying)
GADICKE ANSBERT
10% Owner
Transactions
- Conversion
Common Stock
2015-10-20+595,436→ 595,436 total(indirect: See Footnote) - Conversion
Series B Convertible Preferred Stock
2015-10-20−16,672,224→ 0 total(indirect: See Footnote)→ Common Stock (595,436 underlying)
EVNIN LUKE
10% Owner
Transactions
- Conversion
Common Stock
2015-10-20+595,436→ 595,436 total(indirect: See Footnote) - Conversion
Series B Convertible Preferred Stock
2015-10-20−16,672,224→ 0 total(indirect: See Footnote)→ Common Stock (595,436 underlying)
Scopa James Paul
10% Owner
Transactions
- Conversion
Common Stock
2015-10-20+595,436→ 595,436 total(indirect: See Footnote) - Conversion
Series B Convertible Preferred Stock
2015-10-20−16,672,224→ 0 total(indirect: See Footnote)→ Common Stock (595,436 underlying)
Foley Todd
10% Owner
Transactions
- Conversion
Common Stock
2015-10-20+595,436→ 595,436 total(indirect: See Footnote) - Conversion
Series B Convertible Preferred Stock
2015-10-20−16,672,224→ 0 total(indirect: See Footnote)→ Common Stock (595,436 underlying)
MPM BIOVENTURES V, L.P.
10% Owner
Transactions
- Conversion
Common Stock
2015-10-20+595,436→ 595,436 total(indirect: See Footnote) - Conversion
Series B Convertible Preferred Stock
2015-10-20−16,672,224→ 0 total(indirect: See Footnote)→ Common Stock (595,436 underlying)
KAILIAN VAUGHN M
10% Owner
Transactions
- Conversion
Common Stock
2015-10-20+595,436→ 595,436 total(indirect: See Footnote) - Conversion
Series B Convertible Preferred Stock
2015-10-20−16,672,224→ 0 total(indirect: See Footnote)→ Common Stock (595,436 underlying)
Footnotes (2)
- [F1]The shares of Series B Convertible Preferred Stock (the "Series B Shares") automatically converted into Common Stock on a 1-for-0.03571 basis and had no expiration date.
- [F2]The shares are held as follows: 573,170 by MPM BioVentures V, L.P. ("BV V") and 22,266 by MPM Asset Management Investors BV5 LLC ("AM BV5"). MPM BioVentures V GP LLC ("BV GP") is the general partner of BV V. MPM BioVentures V LLC ("BV LLC") is the managing member of BV GP and AM BV5. Ansbert Gadicke, Luke Evnin, Vaughn M. Kailian, James Paul Scopa and Todd Foley are the members of BV LLC. Each Reporting Person disclaims beneficial ownership of the securities except to the extent of his or its respective pecuniary interest therein.
Documents
Issuer
Cerecor Inc.
CIK 0001534120
Entity typeother
Related Parties
1- filerCIK 0001473930
Filing Metadata
- Form type
- 4
- Filed
- Oct 19, 8:00 PM ET
- Accepted
- Oct 20, 2:59 PM ET
- Size
- 19.9 KB